Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
Lasa Supergenerics Ltd
sales of 2.02 billion Indian Rupees [US$27.65 million]
Themis Medicare Limited
(2.31 billion Indian Rupees [US$31.51 million]
Ina Research Incorporation
based in JAPAN
(2.93 billion Japanese Yen [US$26.69 million]
During the year ended March of 2021, sales at
Hester Pharmaceuticals Limited were 2.14 billion Indian Rupees (US$29.28 million).
increase of 16.9%
versus 2020, when the company's sales were 1.83 billion Indian Rupees .
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2016, sales have increased a total of 112%).